» Articles » PMID: 33798524

National and Regional US Antibiotic Resistance to Helicobacter Pylori: Lessons From a Clinical Trial

Overview
Specialty Gastroenterology
Date 2021 Apr 2
PMID 33798524
Citations 20
Authors
Affiliations
Soon will be listed here.
Citing Articles

Analysis of the status and risk factors for Helicobacter pylori infection and drug resistance in the Lianyungang area, China.

Yang C, Zhang H, Li S, Zhang Z BMC Gastroenterol. 2025; 25(1):96.

PMID: 39979852 PMC: 11843961. DOI: 10.1186/s12876-025-03692-7.


Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysis.

Salahi-Niri A, Nabavi-Rad A, Monaghan T, Rokkas T, Doulberis M, Sadeghi A BMC Med. 2024; 22(1):598.

PMID: 39710669 PMC: 11664859. DOI: 10.1186/s12916-024-03816-y.


Prevalence and resistance of in a predominantly Hispanic population.

Tabesh A, Antillon R, Kondradzhyan M, Tan A World J Gastrointest Endosc. 2024; 16(9):526-532.

PMID: 39351177 PMC: 11438584. DOI: 10.4253/wjge.v16.i9.526.


Incidence trends of gastric cancer in the United States over 2000-2020: A population-based analysis.

Aslani A, Soheili A, Mousavi S, Ebrahimi A, Antar R, Yekta Z PLoS One. 2024; 19(9):e0310040.

PMID: 39321169 PMC: 11423999. DOI: 10.1371/journal.pone.0310040.


Antimicrobial Resistance and the Role of Next-Generation Sequencing.

Andrews C, Herzlinger M, Moss S Gastroenterol Hepatol (N Y). 2024; 20(8):469-476.

PMID: 39205950 PMC: 11348536.


References
1.
El-Serag H, Kao J, Kanwal F, Gilger M, LoVecchio F, Moss S . Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol. 2018; 16(7):992-1002.e6. PMC: 6913173. DOI: 10.1016/j.cgh.2018.03.013. View

2.
Savoldi A, Carrara E, Graham D, Conti M, Tacconelli E . Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology. 2018; 155(5):1372-1382.e17. PMC: 6905086. DOI: 10.1053/j.gastro.2018.07.007. View

3.
Liou J, Malfertheiner P, Lee Y, Sheu B, Sugano K, Cheng H . Screening and eradication of for gastric cancer prevention: the Taipei global consensus. Gut. 2020; 69(12):2093-2112. DOI: 10.1136/gutjnl-2020-322368. View

4.
Graham D . Transitioning of Therapy from Trial and Error to Antimicrobial Stewardship. Antibiotics (Basel). 2020; 9(10). PMC: 7601139. DOI: 10.3390/antibiotics9100671. View

5.
Graham D, Canaan Y, Maher J, Wiener G, Hulten K, Kalfus I . Rifabutin-Based Triple Therapy (RHB-105) for Eradication: A Double-Blind, Randomized, Controlled Trial. Ann Intern Med. 2020; 172(12):795-802. DOI: 10.7326/M19-3734. View